Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Neurological disorders associated with immune checkpoint inhibitors: an association with autoantibodies.
Cancer Immunol Immunother. 2022 Apr;71(4):769-775. doi: 10.1007/s00262-021-03053-9. Epub 2021 Sep 13.
Cancer Immunol Immunother. 2022.
PMID: 34515815
Free PMC article.
Review.
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.
Tokuyasu D, Suzuki S, Uzawa A, Nagane Y, Masuda M, Konno S, Kubota T, Samukawa M, Sugimoto T, Ishizuchi K, Oyama M, Yasuda M, Akamine H, Onishi Y, Suzuki Y, Kawaguchi N, Minami N, Kimura T, Takahashi MP, Murai H, Utsugisawa K.
Tokuyasu D, et al.
Ann Clin Transl Neurol. 2024 May;11(5):1338-1346. doi: 10.1002/acn3.52051. Epub 2024 Apr 4.
Ann Clin Transl Neurol. 2024.
PMID: 38572524
Free PMC article.
Item in Clipboard
Two-year changes of bone mineral density in steroid-treated myasthenia gravis.
Suzuki S.
Suzuki S.
J Bone Miner Metab. 2021 Jul;39(4):723-724. doi: 10.1007/s00774-020-01181-3. Epub 2021 Jan 2.
J Bone Miner Metab. 2021.
PMID: 33389196
No abstract available.
Item in Clipboard
Cite
Cite